Deepak Nitrite Ltd (DEEPAKNTR) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Deepak Nitrite Ltd on NSE and BSE, with an AI summary of each filing.
Submission of Earning Concall Transcript
Transcript · 04 Nov 2026, 4:41 pm
Deepak Nitrite Delivers Record Q2 FY27 Results Driven by Phenolics Expansion Deepak Nitrite reported record Q2 FY27 consolidated revenue of INR 3,091 crore (up 61% YoY, 19% QoQ) and EBITDA of INR 643 crore (up 187% YoY), sustaining a 21% margin. PAT rose 15% QoQ to INR 398 crore. Growth was driven by the Phenolics division, achieving record revenue of INR 2,291 crore and EBIT of INR 515 crore. The company outlined an INR 11,700 crore four-year capex plan, targeting polycarbonate resin commissioning by FY29 and integrated operations by FY30.
Submission of Audio/Video Recording of Earnings Conference Call
Audio / Video · 31 Oct 2026, 12:13 am
Deepak Nitrite Uploads Q2 & H1 FY27 Earnings Call Recording Deepak Nitrite Limited has submitted the audio recording of its Q2 & H1 FY27 earnings conference call to the exchange, pursuant to Regulation 30 of SEBI LODR Regulations, 2015. The call was conducted on 30th Oct'26, and the recording has been made publicly accessible on the company's official website.
Q2 & H1 FY 2026-2027 Results Presentation
Investor Presentation · 30 Oct 2026, 3:35 am
Deepak Nitrite Reports Record Q2 FY27 Financial Performance Driven by Phenolics Deepak Nitrite delivered record results in Q2 FY27, with consolidated revenue rising 61% YoY to ₹3,091 crore, EBITDA surging 187% YoY to ₹643 crore (margin at 20.8%), and PAT jumping 235% YoY to ₹398 crore. Growth was spearheaded by Phenolics, where revenue grew 72% YoY to ₹2,291 crore and EBIT surged 256% YoY to ₹515 crore amid strong domestic realizations and resilient spreads. For H1 FY27, total revenue reached ₹5,682 crore (+48% YoY) and PAT stood at ₹743 crore (+221% YoY).
Unaudited Financial Result for the quarter and half year ended 30th September, 2026
Financial Result · 30 Oct 2026, 12:22 am
Deepak Nitrite Reports Strong Q2 FY27 Results Driven By Phenolics Growth Deepak Nitrite reported a consolidated revenue from operations of ₹3,076.37 Cr for the quarter ended 30th Sep'26, up 61.8% YoY from ₹1,901.89 Cr and 19.3% QoQ. Consolidated net profit surged 234.9% YoY to ₹397.68 Cr from ₹118.75 Cr, with basic EPS rising to ₹29.16. Growth was led by the Phenolics segment, which posted revenue of ₹2,291.09 Cr compared to ₹1,333.46 Cr in Q2 FY26. For H1 FY27, revenue reached ₹5,653.97 Cr with PAT at ₹742.69 Cr. Net operating cash flow stood at ₹650.90 Cr.
Deepak Nitrite Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 30 Oct 2026, 12:11 am
Deepak Nitrite Reports Strong Q2 FY27 Results Driven by Phenolics Growth Deepak Nitrite posted robust consolidated Q2 FY27 results for the quarter ended 30th Sep'26, with revenue from operations surging 61.8% YoY and 19.3% QoQ to ₹3,076.37 crore. Net profit attributable to owners surged 235% YoY and 15.3% QoQ to ₹397.67 crore, yielding a diluted EPS of ₹29.16. Phenolics led top-line momentum, generating ₹2,291.09 crore in revenue with segment PBIT reaching ₹515.43 crore, while Advanced Intermediates contributed ₹810.82 crore. For H1 FY27, consolidated revenue reached ₹5,653.97 crore with PAT at ₹742.69 crore.
Schedule of Q2 & H1 FY 2027 Earnings Con Call
Intimation · 30 Oct 2026, 3:30 pm
Deepak Nitrite Schedules Q2 and H1 FY27 Earnings Call for 30th Oct'26 Deepak Nitrite Ltd. will host its Q2 & H1 FY27 earnings conference call on 30th Oct'26 at 3:30 PM IST to discuss financial results for the quarter and half-year ended 30th Sep'26. The call will be hosted by IIFL Capital, with key management representation including Deputy Managing Director Maulik Mehta, Director – Finance & Group CFO Sanjay Upadhyay, and CFO Somsekhar Nanda. Universal dial-in numbers are +91 22 6280 1259 and +91 22 7115 8160.
To consider and approve the financial results for the quarter and half year ended September 30, 2026
Intimation · 29 Oct 2026, 5:30 am
DEEPAK NITRITE LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 29 Oct 2026, 5:30 am
Deepak Nitrite Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve Un-audited financial results ....
Intimation · 29 Oct 2026, 5:30 am
Deepak Nitrite Schedules Board Meeting to Approve Q2 and H1 Financial Results Deepak Nitrite Limited has scheduled a meeting of its Board of Directors for Thursday, 29th Oct'26. The Board will convene inter alia to consider and approve the standalone and consolidated un-audited financial results of the company for the quarter and half-year ended 30th Sep'26, pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Others (Uncategorized) · 30 Sept 2026, 12:05 am
Deepak Nitrite Commissions Chlorination and Specialty Chemical Plant in Gujarat Deepak Nitrite's material wholly owned subsidiary, Deepak Chem Tech Limited, has commissioned manufacturing operations at its chlorination and specialty chemical plant, along with related utilities and infrastructure, at Dahej, Bharuch district, Gujarat on 29th Sep'26. The total capital expenditure incurred for this project stands at approximately ₹300 Crores as of the commencement of manufacturing operations.
Disclosure under Regulation 30 of SEBI LODR Regulations, 2015
Others (Uncategorized) · 29 Sept 2026, 7:18 pm
Deepak Nitrite's Arm DPL Invests ₹80 Crore in DCTL via OCRPS On 29th Sep'26, Deepak Chem Tech Limited (DCTL) allotted 80,00,000 9% Optionally Convertible Redeemable Preference Shares (OCRPS) at ₹100 each, aggregating to ₹80 Crores, to Deepak Phenolics Limited (DPL) on an arm's-length basis. Both entities are wholly owned subsidiaries of Deepak Nitrite Limited. The cash infusion aims to strengthen DCTL's capital base, fund project expenses, and support general corporate purposes across its Gujarat chemical plants. DCTL reported a turnover of ₹172.23 Crores for FY 2025-26, compared to ₹9.43 Crores in FY 2024-25.
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Others (Uncategorized) · 26 Aug 2026, 11:55 pm
Deepak Nitrite and Subsidiary Invest ₹175 Crore in Deepak Chem Tech Deepak Nitrite (DNL) and its subsidiary Deepak Phenolics (DPL) have invested ₹175 crore in Deepak Chem Tech (DCTL), another wholly-owned subsidiary. The investment, completed on 26th Aug'26, was made via 9% Optionally Convertible Redeemable Preference Shares. DPL invested ₹95 crore and DNL invested ₹80 crore. The funds will strengthen DCTL's capital base and support project expenses for its fluorination, nitration, and hydrogenation plants. DCTL reported a turnover of ₹172.23 crore in FY26. The transaction is a related-party transaction conducted at arm's length.
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Others (Uncategorized) · 25 Aug 2026, 11:22 pm
Deepak Nitrite Subsidiary Settles Factory Rules Violation for ₹3 Lakh Deepak Nitrite's wholly-owned subsidiary, Deepak Chem Tech Limited (DCTL), has received a settlement order dated 25th Aug'26 from the Chief Inspector for factories in Gujarat. DCTL settled a violation of Rule 102 of the Gujarat Factories Rules, 1963, by paying a penalty of ₹3,00,000. The order was issued under the Occupational Safety, Health and Working Condition Code, 2020. The company stated there will be no material financial impact beyond the settlement amount.
Disclosure under Regulation 30 of SEBI LODR Regulations - Resignation of Shri Puneet Sharma, SBU Head - Life Sciences of the Company
Change in Management · 21 Aug 2026, 11:55 pm
Deepak Nitrite: Life Sciences SBU Head Resigns Mr. Puneet Sharma, SBU Head of the Life Sciences division, has resigned from Deepak Nitrite to pursue an external career opportunity. His resignation is effective from the close of business on 21st Aug'26. Mr. Sharma will serve a three-month notice period to ensure a seamless transition for ongoing business development, technology platforms, and the onboarding of his successor. The Life Sciences division focuses on agrochemical and pharma intermediates, personal care, and other emerging platforms.
Earnings Call Transcript Q1 FY 2027
Transcript · 11 Aug 2026, 9:21 pm
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Others (Uncategorized) · 07 Aug 2026, 10:27 pm
Deepak Nitrite Confirms Updated Board of Directors Composition Deepak Nitrite Limited has confirmed its updated Board of Directors composition effective 7th Aug'26. The change follows the previously announced cessation of Shri Dileep Choksi as an Independent Director. The reconstituted board now comprises 13 members, including six Executive/Managing Directors and seven Independent Directors. Key leadership roles remain with Dr. Deepak C. Mehta as Chairman & MD, supported by two Deputy MDs. This formalizes the board structure following changes announced on 3rd Apr'26 and 15th May'26, ensuring governance continuity.
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Change in Management · 07 Aug 2026, 10:09 pm
Deepak Nitrite: Independent Director Dileep Choksi's Term Ends Deepak Nitrite announced that Shri Dileep Choksi (DIN: 00016322) has ceased to be an Independent Director effective 7th Aug'26. The change in board composition is due to the completion of his second term, as per the company's disclosure under Regulation 30 of SEBI Listing Regulations. This represents a planned departure from the company's board of directors.
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Others (Uncategorized) · 07 Aug 2026, 12:25 am
Deepak Nitrite's Subsidiary Commissions ₹735 Crore Plant in Dahej Deepak Nitrite's material wholly owned subsidiary, Deepak Chem Tech Limited, has commissioned its new plant in Dahej, Gujarat on 6th Aug'26. The facility will manufacture Methyl Isobutyl Ketone (MIBK) & Methyl Isobutyl Carbinol (MIBC). The total capital expenditure for the plant, including offsite utilities and infrastructure, amounted to approximately ₹735 Crores as of the commencement of operations. This marks a significant capacity expansion for the company in key chemical intermediates.
Submission of Video Recordings of Earnings Conference Call
Audio / Video · 06 Aug 2026, 11:25 pm
Deepak Nitrite Uploads Q1 & FY27 Earnings Call Recording Deepak Nitrite has submitted the audio recording of its Q1 & FY 2027 earnings conference call, held on Aug 6, '26. The recording is now available on the company's website. This submission complies with SEBI's Regulation 30 regarding disclosure requirements.
Voting Results of 55th Annual General Meeting held on 5th August, 2026
Annual General Meeting · 06 Aug 2026, 3:47 am
Proceedings of 55th Annual General Meetings
Annual General Meeting · 06 Aug 2026, 2:34 am
Q1 - FY 2027 Investor Presentation
Investor Presentation · 05 Aug 2026, 4:12 am
Deepak Nitrite: Record Q1 FY27 Results Driven by Strong Phenolics Performance Deepak Nitrite reported its highest-ever quarterly performance for Q1 FY27 on 4th Aug'26. Consolidated revenue grew 35% YoY to ₹2,592 Cr, while EBITDA surged 159% YoY to ₹554 Cr, expanding margins to 21%. PAT jumped 207% YoY to ₹345 Cr. The Phenolics segment was the primary driver, with revenue up 36% YoY to ₹1,775 Cr and EBIT growing 254% YoY to ₹418 Cr. Advanced Intermediates also saw solid revenue growth of 33% YoY. The company's domestic-to-export revenue mix stood at 85:15.
Press Release
Press Release · 04 Aug 2026, 11:31 pm
Deepak Nitrite Announces ₹2,500 Crore Capex for Bisphenol A Plant Deepak Nitrite's subsidiary, Deepak Chem Tech Ltd, announced on 4th Aug'26 a ₹2,500 crore capex plan to manufacture Bisphenol A (BPA). The new greenfield project will have a capacity of up to 240 KTA and will be funded via debt and equity. This move aims to create a highly integrated manufacturing platform, spanning from Cumene to Phenol, Acetone, BPA, and Polycarbonate resins. The BPA facility will meet captive requirements for its upcoming Polycarbonate plant and also cater to India's growing Epoxy resins market.
Appointment of Chief Executive Officer - Advanced Intermediates Business of the Company
Change in Management · 04 Aug 2026, 11:29 pm
Deepak Nitrite Appoints Lohit Shringi as CEO of Advanced Intermediates Business Deepak Nitrite's Board of Directors has approved the appointment of Shri Lohit Shringi as the Chief Executive Officer of its Advanced Intermediates business, effective 4th Aug'26. Shringi brings over 27 years of leadership experience in P&L management, strategy, and operations. He previously served as Executive Director and Chief of Specialty Chemicals at PCBL Chemical Limited. His prior experience includes leadership roles at DuPont. This appointment is for a permanent position and is aimed at steering a key business segment for the company.
Results- Unaudited Financial Results for the quarter ended 30th June, 2026
Financial Result · 04 Aug 2026, 11:24 pm
Deepak Nitrite Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Crore) ■ Revenue: 2,578 (+36.4% YoY | +21.6% QoQ) ■ EBITDA: 540 (+185.0% YoY | +43.7% QoQ) ■ EBITDA Margin (%): 21.0 (+1093 bps YoY | +322 bps QoQ) ■ PAT: 345 (+207.5% YoY | +57.0% QoQ) ■ EPS (INR): 25.3 (+207.4% YoY | +57.0% QoQ) Deepak Nitrite Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Crore) Segmental Performance Advanced Intermediates ■ Revenue: 804 (+32.8% YoY | +13.6% QoQ) ■ EBIT: 67.0 (+88.8% YoY | +99.5% QoQ) ■ EBIT Margin (%): 8.3 (+247 bps YoY | +359 bps QoQ) Phenolics ■ Revenue: 1,775 (+36.1% YoY | +24.2% QoQ) ■ EBIT: 418 (+254.3% YoY | +45.8% QoQ) ■ EBIT Margin (%): 23.5 (+1449 bps YoY | +349 bps QoQ)